Organogenesis Holdings (ORGO) FCF Margin Growth (1y) (2018 - 2026)

Organogenesis Holdings (ORGO) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 74.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -1,043.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -573.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 734.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 301.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -45,890.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 407.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 610.00
10 Organogenesis Holdings 317.58 Mn 225.48 Mn 11.46 Mn 7,548.00

Historic Data

Download Data
DateValue
Mar 31, 2026 7,548.00
Dec 31, 2025 943.00
Sep 30, 2025 -476.00
Jun 30, 2025 -3,724.00
Mar 31, 2025 -1,722.00
Dec 31, 2024 -133.00
Sep 30, 2024 755.00
Jun 30, 2024 -1,112.00
Mar 31, 2024 179.00
Dec 31, 2023 979.00
Sep 30, 2023 200.00
Jun 30, 2023 1,285.00
Mar 31, 2023 -1,127.00
Dec 31, 2022 672.00
Sep 30, 2022 -3,120.00
Jun 30, 2022 -1,155.00
Mar 31, 2022 109.00
Dec 31, 2021 -4,016.00
Sep 30, 2021 2,568.00
Jun 30, 2021 2,509.00